Study shows mRNA-based COVID vaccines enhance effectiveness of immune checkpoint therapy
Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice…
Researchers develop a novel approach to monitor CD8⁺ T cell activity over time
The ability of immune cells-particularly CD8+ T cells-to launch a rapid burst of proliferation inside tumors is key…
Epigenetic editing enables safer and more effective T cell therapies
Arc Institute, Gladstone Institutes, and University of California, San Francisco, scientists have developed an epigenetic editing platform that…
Leveraging the microbiome to promote healthy living and aging
From probiotic pills to skincare products to dedicated meal plans, the microbiome is all the rage in the…
UnitedHealth’s ‘Optum Real’ Uses AI to Speed Up Medical Claims
UnitedHealth Group Inc. is testing a new system to streamline how medical claims are processed, an early example…
Study suggests earlier start of hormone therapy optimizes long-term health outcomes
Menopause may take a toll on women physically and emotionally due to declining estrogen levels. For some, the…
Advocate and cancer survivor Lainie Jones dies at 41 in Fort Lauderdale
Lainie Jones believed in the power of being early. She credited early detection as the reason she survived…
Study reveals protein plaques in neurodegeneration function as enzymes, breaking down ATP
A new study led by Rice University’s Pernilla Wittung-Stafshede has revealed that protein clumps, or plaques that clog…
Researchers engineer a tool to dismantle cancer’s RNA-built growth hubs
In a city, coworking hubs bring people and ideas together. Inside cancer cells, similar hubs form-but instead of…
New insights reveal persistent genome structure during cell division
Before cells can divide, they first need to replicate all of their chromosomes, so that each of the…
Stroud woman survived cancer but life changed after doctors prescribed painkillers
Stevie Davis was prescribed opioid co-codamol, an effective painkiller, but one that can result in dependence, and this…
PSMAddition data show Novartis Pluvicto™ delays progression to end-stage prostate cancer
PluvictoTM plus standard of care (ARPI + ADT) significantly reduced risk of progression or death by 28% (HR…